TGF-β signaling and the fibrotic response
The DOI matches its Crossref record; 152 of the 153 references it cites were found in a registry or an index.
Abstract
The cause of fibrotic diseases, pathologies characterized by excessive production, deposition, and contraction of extracellular matrix, is unknown. To understand the molecular basis of fibrotic disease, it is essential to appreciate how matrix deposition is normally controlled and how this process is dysregulated in fibrogenesis. This review discusses the current state of knowledge concerning interactions among the profibrotic proteins transforming growth factor‐β (TGF‐β), connective tissue growth factor (CTGF, CCN2), and ED‐A fibronectin (ED‐A FN) and the antifibrotic proteins tumor necrosis factor‐α (TNF‐α) and γ‐interferon (IFN‐γ).—Leask, A., Abraham, D. J. TGF‐β signaling and the fibrotic response. FASEB J. 18, 816–827 (2004)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TGF-β is the critical mediator of pathological fibrosis after myocardial injury [64].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [64]
In the citing paper
“TNFα also suppresses the TGFβ stimulation of ECM production.62”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [62]
Citations
Cites
1 retracted
RETRACTED: Deficient Smad7 expression: A putative molecular defect in scleroderma
Dong, C., Zhu, S., Wang, T., Yoon, W., Li, Z., Alvarez, R. J., ten Dijke, P., White, B., Wigley, F. M., & Goldschmidt-Clermont, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062010399 · Cited by 244 · cited 1×
“Although one report showed decreased levels of the inhibitory Smad7 in scleroderma fibroblasts (94), two other studies showed no difference in Smad7 levels between normal and scleroderma fibroblasts (65, 91); thus, Smad7 deficiency does not seem to be a general feature of scleroderma fibroblasts.”
ResultRetractedMassagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556 · cited 4×
“The TGF- superfamily includes nearly 30 proteins in mammals including TGF- s, activins and inhibins, nodal, myostatin, bone morphogenetic proteins (BMPs), growth/differentiation factors (GDFs), and anti-Müllerian hormone (AMH, also called Müllerianinhibiting substance or MIS) (15, 16).”
BackgroundInfluentialDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 2×
“Transcriptional responses induced by IFN- in most cells are mediated through the Jak-Stat pathway (146).”
BackgroundCELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890 · cited 1×
“IFN- , a pleiotropic cytokine produced by T cells and NK cells, plays fundamental roles in innate and acquired immune responses (145).”
BackgroundYu, Q., & Stamenkovic, I. (2000) · PubMed Central · Cited by 2,203
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076 · cited 1×
“TSP-1 null mice demonstrate a partial phenotypic overlap with TGF- 1 null animals (30), and integrin 6 / are highly resistant to lung fibrosis induced by the profibrotic drug bleomycin (31).”
BackgroundIdentification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754 · cited 1×
“For example, the plasmin proteases MMP-2 and -9, which promote matrix degradation (24), activate TGF- (25, 26).”
BackgroundThe myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630 · cited 5×
“observed in lesions of fibrotic disease (2).”
BackgroundInfluentialMaking sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
Research works printed but not linked: 3
- 10.1111/j.1523-1755.2002.kid567.x · doi:10.1111/j.1523-1755.2002.kid567.x · Paper page
- Schmid P., 1998, Enhanced expression oftransforming growth factor-beta type and type II receptors in wound granulation tissue and hyper trophic scar, Am. J. Pathol., 152, 485
- 10.1111/j.1523-1755.1998.00820.x · doi:10.1111/j.1523-1755.1998.00820.x · Paper page
Cited by
Items 501–600 of 1,008
Mizutani, M., Ito, Y., Mizuno, M., Nishimura, H., Suzuki, Y., Hattori, R., Matsukawa, Y., Imai, M., Oliver, N., Goldschmeding, R., et al. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00368.2009 · Cited by 76
Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition
Wang, S., Shi, X., Feng, M., Wang, X., Zhang, Z., Zhao, X., Han, B., Ma, H., Dai, B., & Ding, Y.-T. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.06.008 · Cited by 77
Matharu, Z., Patel, D., Gao, Y., Haque, A., Zhou, Q., & Revzin, A. (2014) · Analytical Chemistry · doi:10.1021/ac502383e · Cited by 85
Genetic background determines mouse strain differences in inflammatory angiogenesis
Marques, S. M., Campos, P. P., Castro, P. R., Cardoso, C. C., Ferreira, M. A. N. D., & Andrade, S. P. (2011) · Microvascular Research · doi:10.1016/j.mvr.2011.08.011 · Cited by 85
“TGF-β1 is a key pro-fibrotic cytokine that induces differentiation of fibroblasts into myofibroblasts that in turn synthesize collagen (Bonniaud et al., 2005; Leask and Abraham, 2004).”
BackgroundSignaling pathways involving adenosine A2A and A2B receptors in wound healing and fibrosis
Shaikh, G., & Cronstein, B. N. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9498-3 · Cited by 91
Blood derivatives awaken in regenerative medicine strategies to modulate wound healing
Mendes, B. B., Gómez‐Florit, M., Babo, P. S., Domingues, R. M. A., Reis, R. L., & Gomes, M. E. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.018 · Cited by 75
Understanding the mechanism of radiation induced fibrosis and therapy options
Ejaz, A., Greenberger, J. S., & Rubin, P. J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107399 · Cited by 77
MiR‐9‐5p protects from kidney fibrosis by metabolic reprogramming
Fierro‐Fernández, M., Miguel, V., Márquez‐Expósito, L., Nuevo‐Tapioles, C., Herrero, J. I., Blanco, E. M., Tituaña, J., Castillo, C., Cannata, P., Monsalve, M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901599rr · Cited by 76
ALK1-Smad1/5 signaling pathway in fibrosis development: Friend or foe?
Muñoz‐Félix, J. M., González-Núñez, M., & López-Novoa, J. M. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.08.002 · Cited by 82
Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways
Wang, W., Qu, M., Xu, L., Wu, X., Gao, Z., Gu, T., Zhang, W., Ding, X., Liu, W., & Chen, Y.-L. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1430-3 · Cited by 78
Garbuzenko, O. B., Ivanova, V., Kholodovych, V., Reimer, D. C., Reuhl, K. R., Yurkow, E. J., Adler, D., & Minko, T. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.04.005 · Cited by 74
Tsuda, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092787 · Cited by 80
Epithelial–Mesenchymal Transition Mechanisms in Chronic Airway Diseases: A Common Process to Target?
Mottais, A., Riberi, L., Falco, A., Soccal, S., Gohy, S. T., & Rose, V. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512412 · Cited by 76
“TGF-β1 is the first isoform to have been identified [25], and it has been found to play a crucial role in fibrotic lung diseases [26,32–37], particularly in airway remodelling [38,39].”
BackgroundWang, Y.-W., Liou, N.-H., Cherng, J., Chang, S., Ma, K., Fu, E., Liu, J.-C., & Dai, N. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.84 · Cited by 84
“However, many kinds of cells energetically produce TGF-b in the wound healing process (Leask and Abraham, 2004), making it difficult to block a large amount of TGF-b in the environment of wound repair.”
BackgroundInfluentialRamirez, F., Tanaka, S., & Bou–Gharios, G. (2006) · Matrix Biology · doi:10.1016/j.matbio.2006.05.002 · Cited by 73
Cell Signals Influencing Hepatic Fibrosis
Cong, M., Iwaisako, K., Jiang, C., & Kisseleva, T. (2012) · International Journal of Hepatology · doi:10.1155/2012/158547 · Cited by 77
“degradation of the LAP/LTBP complex [26].”
Cho, N., Razipour, S. E., & McCain, M. L. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370218761628 · Cited by 80
Recent advances in fibroblast signaling and biology in scleroderma
Pannu, J., & Trojanowska, M. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000137894.63091.1a · Cited by 73
Valle-Tenney, R., Rebolledo, D. L., Lipson, K. E., & Brandan, E. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.09.003 · Cited by 74
Collagen Fibril Density Modulates Macrophage Activation and Cellular Functions during Tissue Repair
Sapudom, J., Mohamed, W. K. E. A., Garcia‐Sabaté, A., Alatoom, A., Karaman, S., Mahtani, N., & Teo, J. C. M. (2020) · Bioengineering · doi:10.3390/bioengineering7020033 · Cited by 74
Russo, R. C., Garcia, C. C., Barcelos, L. S., Rachid, M. A., Guabiraba, R., Roffê, E., Souza, A. L. S., Sousa, L. P., Mirolo, M., Doni, A., et al. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0610346 · Cited by 73
“IFN- is a cytokine with antifibrotic proprieties, which may act in the context of lung fibrosis as a negative regulator of TGF- 1 production and action [40].”
BackgroundZheng, C., Fang, Y., Tong, W., Li, G., Wu, H., Zhou, W., Lin, Q., Yang, F., Yang, Z., Wang, P., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401117t · Cited by 77
Kindlins: Roles in development and cancer progression
Zhan, J., & Zhang, H. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.03.008 · Cited by 77
Epithelial Cell Cycle Behaviour in the Injured Kidney
Moonen, L., D’Haese, P. C., & Vervaet, B. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072038 · Cited by 74
“This establishes a pro-fibrotic micro-environment by which resident fibroblasts become permanently activated [70], i.e., they persistently proliferate and excessively deposit ECM [15,71,72].”
BackgroundInfluentialMEGAKARYOCYTE CONTRIBUTION TO BONE MARROW FIBROSIS: MANY ARROWS IN THE QUIVER
Malara, A., Abbonante, V., Zingariello, M., Migliaccio, A. R., & Balduini, A. (2018) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2018.068 · Cited by 78
Morry, J., Ngamcherdtrakul, W., Gu, S., Goodyear, S. M., Castro, D. J., Reda, M. M., Sangvanich, T., & Yantasee, W. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.005 · Cited by 75
“Fibrosis is a complex disease characterized by increased oxidative stress [1,2], persistent inflammation [3,4], elevated levels of profibrotic and proinflammatory cytokines [5e7], and an excessive synthesis and accumulation of extracellular matrices, mainly consisting of collagen [6,7].”
BackgroundSmad3 mediates TGF-β1 induction of VEGF production in lung fibroblasts
Kobayashi, T., Liu, X., Wen, F., Fang, Q., Abe, S., Wang, X. Q., Hashimoto, M., Shen, L., Kawasaki, S., Kim, H. J., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.032 · Cited by 72
miR-1343 attenuates pathways of fibrosis by targeting the TGF-β receptors
Stolzenburg, L. R., Wachtel, S., Dang, H., & Harris, A. (2015) · Biochemical Journal · doi:10.1042/bj20150821 · Cited by 77
Chen, R., Xue, J., & Xie, M.-L. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.05.015 · Cited by 71
“TGF-β is an important fibrogenic cytokine in the fibrotic response of heart [22] and includes three subtypes (TGF-β1, TGF-β2 and TGF-β3) in mammalian cells.”
BackgroundRoffe, S., Hagai, Y., Pines, M., & Halevy, O. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.01.003 · Cited by 75
Modifying muscular dystrophy through transforming growth factor‐β
Ceco, E., & McNally, E. M. (2013) · FEBS Journal · doi:10.1111/febs.12266 · Cited by 76
Kryger, Z. B., Sisco, M., Roy, N. K., Lu, L., Rosenberg, D. S., & Mustoe, T. A. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.03.001 · Cited by 71
The Role(s) of Cytokines/Chemokines in Urinary Bladder Inflammation and Dysfunction
Gonzalez, E. J., Arms, L., & Vizzard, M. A. (2014) · BioMed Research International · doi:10.1155/2014/120525 · Cited by 82
A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K
Panwar, P., Søe, K., Guido, R. V., Bueno, R. V. C., Delaisse, J., & Brömme, D. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13383 · Cited by 71
“Deregulation of TGF-ß1 expression and metabolism has been associated with fibrotic diseases including morphea (Leask and Abraham, 2004), which was the terminating factor of the balicatib clinical trial (Runger et al., 2012).”
BackgroundFaust, S. M., Lu, G., Marini, B. L., Zou, W., Gordon, D., Iwakura, Y., Laouar, Y., & Bishop, D. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902446 · Cited by 69
“It has been reported that sustained production of TGF in tissues is a main contributor to the development of fibrosis (57, 81), but we have observed that gene transfer of TGF in syngeneic grafts fail to develop CR (45).”
BackgroundTransforming growth factor-β signaling in systemic sclerosis
Nolan, B., Chenming, S., & Chen, S. (2018) · Journal of Biomedical Research · doi:10.7555/jbr.31.20170034 · Cited by 71
STAT5 signaling in normal and pathologic hematopoiesis
Kevin, D. B. (2006) · Frontiers in bioscience · doi:10.2741/2274 · Cited by 73
HIF-hypoxia signaling in skeletal muscle physiology and fibrosis
Valle-Tenney, R., Rebolledo, D. L., Acuña, M. J., & Brandan, E. (2020) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-020-00553-8 · Cited by 72
“…growth factor β (TGF-β) signaling has been described as the master fibrotic driver in several organs and tissues including skeletal muscle, where is up-regulated in fibrosis-related pathologies of diverse etiology (CabelloVerrugio et al. 2012b; Ismaeel et al. 2019; Leask and Abraham 2004).”
BackgroundTackling the glial scar in spinal cord regeneration: new discoveries and future directions
Shafqat, A., Albalkhi, I., Magableh, H. M., Saleh, T., AlKattan, K. M., & Yaqinuddin, A. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1180825 · Cited by 79
“These distinct stromal cell populations are differentially recruited to the SCI lesion site, where they respond to fibrogenic factors such as TGF-β and elaborate ECM components, including collagen, laminins, fibronectin, and CSPGs leading to the formation of the fibrotic scar (Leask and Abraham, 2004; Klapka and Mülle…”
BackgroundTumelty, K. E., Smith, B. D., Nugent, M. A., & Layne, M. D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.502617 · Cited by 70
“TGF itself is not considered to be a good IPF drug target because of the chronic nature of the disease (54) and because blocking TGF long-term could lead to many detrimental side effects.”
BackgroundHeo, S.-J., Han, W. M., Szczesny, S. E., Cosgrove, B. D., Elliott, D. M., Lee, D. A., Duncan, R. L., & Mauck, R. L. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.07.006 · Cited by 77
Biological Principles of Scar and Contracture
Kwan, P. O., & Tredget, E. E. (2017) · Hand Clinics · doi:10.1016/j.hcl.2016.12.004 · Cited by 75
The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3
Németh, Á., Mozes, M. M., Calvier, L., Hansmann, G., & Kökény, G. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1431-x · Cited by 78
Hayashida, T., Wu, M.-H., Pierce, A., Poncelet, A.-C., Varga, J., & Schnaper, H. W. (2007) · Journal of Cell Science · doi:10.1242/jcs.03492 · Cited by 70
“Among the pathophysiological roles of this multi-functional cytokine, induction of extracellular matrix (ECM) expression is one of the crucial steps of the sclerosing process, not only in the kidney but also in fibrosis of other organs such as the lungs and skin (Leask and Abraham, 2004).”
BackgroundTreatment of Radiation‐Induced Brain Necrosis
Yang, X., Ren, H., & Fu, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4793517 · Cited by 73
“TGF-β1 can regulate immune inflammatory response as a two-way regulator of proinflammatory or antiinflammatory response [75].”
BackgroundBrigstock, D. R. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0043-9 · Cited by 69
“…actions of TNF-α were initially attributed to interference of TGF-β pathways either by NF-κB-mediated induction of Smad7 or JNKmediated suppression of Smad 3 (Leask and Abraham 2004), the data now suggest that these pathways are overridden or inoperative under some circumstances in some cell types.”
BackgroundInfluentialDuflo, S. M., Thibeault, S. L., Li, W., Shu, X. Z., & Prestwich, G. D. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.3201 · Cited by 69
CTGF, intestinal stellate cells and carcinoid fibrogenesis
Kidd, M. S. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i39.5208 · Cited by 69
Wang, P., Wang, Y., Nie, X., Braïni, C., Bai, R., & Chen, C. (2014) · Small · doi:10.1002/smll.201303588 · Cited by 76
Bhogal, R. K., & Bona, C. A. (2008) · International Reviews of Immunology · doi:10.1080/08830180802430974 · Cited by 69
Baron, D., Montfort, J., Houlgatte, R., Fostier, A., & Guiguen, Y. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-357 · Cited by 69
“Matrix protein synthesis and the concomitant decrease in matrix proteinase activity have been well described as a characteristic fibrotic response of an excessive Transforming Growth Factor-beta (TGFβ) production [18,19].”
BackgroundRemst, D. F. G., Davidson, E. N. B., Vitters, E. L., Bank, R. A., van den Berg, W. B., & van der Kraan, P. M. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1740-5 · Cited by 69
Thrombopoietin/TGF-β1 Loop Regulates Megakaryocyte Extracellular Matrix Component Synthesis
Abbonante, V., Buduo, C. A. D., Gruppi, C., Malara, A., Gianelli, U., Celesti, G., Anselmo, A., Laghi, L., Vercellino, M., Visai, L., et al. (2016) · Stem Cells · doi:10.1002/stem.2285 · Cited by 73
Budi, E. H., Muthusamy, B.-P., & Derynck, R. (2015) · Science Signaling · doi:10.1126/scisignal.aaa9432 · Cited by 67
Kreuter, A. (2012) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2012.01479.x · Cited by 96
Fibroblast fate regulation by time dependent TGF-β1 and IL-10 stimulation in biomimetic 3D matrices
Sapudom, J., Wu, X., Chkolnikov, M., Ansorge, M., Anderegg, U., & Pompe, W. (2017) · Biomaterials Science · doi:10.1039/c7bm00286f · Cited by 76
Hsieh, Y., Wu, K., Chen, H., & Deng, Y. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2017.07.003 · Cited by 69
Jansen, H. J., Mackasey, M., Moghtadaei, M., Liu, Y., Kaur, J., Egom, E. E. A., Tuomi, J. M., Rafferty, S. A., Kirkby, A. W., & Rose, R. A. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.118.006863 · Cited by 74
Park, J., Yoon, J., Lee, K. Y., & Park, B. (2015) · Biochimie · doi:10.1016/j.biochi.2015.03.015 · Cited by 69
RetractedIslam, S. S., Mokhtari, R. B., Hout, Y. E., Azadi, M. A., Alauddin, M., Yeger, H., & Farhat, W. A. (2013) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-013-0216-4 · Cited by 70
“Studies have shown that TGF-β1 plays a critical role in wound healing, deposition of matrix molecules and induces fibrotic response in vivo (Leask and Abraham 2004).”
BackgroundInfluentialSingh, V. K., Hanlon, B. K., Santiago, P. T., & Seed, T. M. (2017) · International Journal of Radiation Biology · doi:10.1080/09553002.2017.1332440 · Cited by 68
“Pulmonary fibrosis is a complication arising from chemo- and radiotherapy for thoracic malignancies (Leask & Abraham 2004).”
BackgroundMicroRNA-145 Antagonism Reverses TGF-β Inhibition of F508del CFTR Correction in Airway Epithelia
Kabir, F. M. L., Ambalavanan, N., Liu, G., Li, P., Solomon, G. M., Lal, C. V., Mazur, M., Halloran, B., Szul, T., Gerthoffer, W. T., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201704-0732oc · Cited by 69
“As TGF-b is a pluripotent regulator of cellular functions including cell differentiation, repair, and remodeling (11, 12), it is important to ascertain the precise mechanisms by which TGF-b modifies CFTR function and CF lung disease.”
BackgroundLeonurine: From Gynecologic Medicine to Pleiotropic Agent
Li, Y., Lin, Y., Liu, X., Wang, L., Yu, M., Li, D., Zhu, Y. Z., & Du, M. (2019) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-019-3453-0 · Cited by 69
Modulation of wound healing during and after glaucoma surgery
Georgoulas, S., Dahlmann-Noor, A. H., Brocchini, S., & Khaw, P. T. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)01117-5 · Cited by 67
“Inhibiting Smad3 in immediate postoperative applications might prove beneficial (Leask and Abraham, 2004).”
BackgroundYuen, D. A., Connelly, K. A., Advani, A., Liao, C., Kuliszewski, M. A., Trogadis, J. E., Thai, K., Advani, S. L., Zhang, Y., Kelly, D. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009543 · Cited by 67
Takai, E., Tsukimoto, M., & Kojima, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076346 · Cited by 68
Regulation of pancreatic function by connective tissue growth factor (CTGF, CCN2)
Charrier, A., & Brigstock, D. R. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.07.001 · Cited by 74
“As in many other organ systems [38,39], over-expression of TGF-b is strongly associated with inflammation and fibrosis in the pancreas.”
BackgroundSkeletal muscle fibrosis develops in response to desmin deletion
Meyer, G. A., & Lieber, R. L. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00441.2011 · Cited by 72
Oyama, M. A., & Levy, R. J. (2009) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2009.0411.x · Cited by 82
Shi-wen, X., Thompson, K., Khan, K., Liu, S., Murphy-Marshman, H., Baron, M., Denton, C. P., Leask, A., & Abraham, D. J. (2012) · Rheumatology · doi:10.1093/rheumatology/kes234 · Cited by 65
Self-citationBu, S., Kuijer, R., van der Worp, R. J., Postma, G., de Lavalette, V. W. R., Li, X., Hooymans, J. M. M., & Los, L. I. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15971 · Cited by 77
Chen, H., Qian, Z., Zhang, S., Tang, J. X., Fang, L., Jiang, F., Ge, D., Chang, J., Cao, J., Yang, L., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101774 · Cited by 75
The role of Th17 cells in viral infections
Aghbash, P. S., Hemmat, N., Nahand, J. S., Shamekh, A., Memar, M. Y., Babaei, A., & Baghi, H. B. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107331 · Cited by 70
Ramirez, A. M., Shen, Z., Ritzenthaler, J. D., & Roman, J. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01430.x · Cited by 66
Lopes, L. B., Furnish, E. J., Komalavilas, P., Flynn, C. R., Ashby, P., Hansen, A., Ly, D. P., Yang, G. P., Longaker, M. T., Panitch, A., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.264 · Cited by 66
“CTGF has been proposed to mediate some of the profibrotic effects of TGF-b, including fibroblast proliferation and the production of extracellular matrix proteins such as collagen and fibronectin (Duncan et al., 1999; Leask and Abraham, 2004, 2006).”
BackgroundInfluentialPorphyromonas gingivalis downregulates the immune response of fibroblasts
Palm, E. C., Khalaf, H., & Bengtsson, T. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-155 · Cited by 73
“The fibroblasts are a source of connective tissue that maintain tissue haemostasis and integrity, and play an important role in tissue generation after wounding as well as in the pathogenesis of fibrotic inflammatory diseases and excessive scarring involving extracellular matrix accumulation [16].”
Mun, J., Kim, Y., Kim, B., Kim, J. H., Kim, M., & Ko, H. (2013) · Wound Repair and Regeneration · doi:10.1111/wrr.12136 · Cited by 67
High Throughput Determination of TGFβ1/SMAD3 Targets in A549 Lung Epithelial Cells
Zhang, Y., Handley, D., Kaplan, T., Yu, H., Bais, A. S., Richards, T. J., Pandit, K. V., Zeng, Q., Benos, P. V., Friedman, N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020319 · Cited by 76
“In most cell types, TGFb1 inhibits cell proliferation [17].”
BackgroundPant, I., Rao, S. G., & Kondaiah, P. (2016) · Scientific Reports · doi:10.1038/srep34314 · Cited by 71
Wound healing in cutaneous leishmaniasis: A double edged sword of IL-10 and TGF-β
Abdoli, A., Maspi, N., & Ghaffarifar, F. (2017) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2017.02.001 · Cited by 77
Sun, L., Yuan, Q., Xu, T., Yao, L., Feng, J., Ma, J., Wang, L., Lu, C., & Wang, D. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00545 · Cited by 66
“As an early biomarker of fibrosis, TGF-β1 induces Frontiers in Pharmacology | www.frontiersin.org 7 August 2017 | Volume 8 | Article 545 synthesis of ECM components such as collagen and fibronectin (Leask and Abraham, 2004).”
BackgroundThe multifaceted roles of perlecan in fibrosis
Lord, M. S., Tang, F., Rnjak‐Kovacina, J., Smith, J. G. W., Melrose, J., & Whitelock, J. M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.02.013 · Cited by 69
Zhang, X., Lu, H., Xie, S., Wu, C., Guo, Y., Xiao, Y., Zheng, S., Zhu, H., Zhang, Y., & Bai, Y. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14842 · Cited by 69
“TGF‐β1 can initiate a cellular response by binding to its receptor, which leads to Smad2/3 phosphorylation and translocation into the nucleus where profibrotic genes are transcribed (Lan & Chung, 2012; Leask & Abraham, 2004).”
BackgroundExtracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics
Brigstock, D. R. (2021) · Cells · doi:10.3390/cells10071596 · Cited by 68
BMP-7 counteracting TGF-beta1 activities in organ fibrosis
Weiskirchen, R., & Meurer, S. K. (2013) · Frontiers in bioscience · doi:10.2741/4189 · Cited by 75
Rodrigues-Díez, R. R., Rodrigues‐Díez, R., Lavoz, C., Rayego‐Mateos, S., Civantos, E., Rodríguez‐Vita, J., Mezzano, S. A., Ortíz, A., Egido, J., & Ruiz‐Ortega, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014145 · Cited by 65
“TGF-β is implicated in many human fibrotic disorders. TGF-β is one of the most potent inducers of ECM proteins in fibroblasts and contributes to epithelial mesenchymal transition (EMT) in different tissues”
BackgroundWang, W., Liu, F., & Chen, N. (2007) · Mediators of Inflammation · doi:10.1155/2007/62641 · Cited by 65
“Phosphorylated Smad2/Smad3 (p-Smad2/3) is the main signaling pathway of TGF-β1 and it participates in the biological effects of TGF-β which include cell proliferation, inflammation reaction, and fibrosis [24, 25].”
BackgroundPechkovsky, D. V., Hackett, T. L., An, S. S., Shaheen, F., Murray, L. A., & Knight, D. A. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0318oc · Cited by 64
Nair, A. R., Elks, C. M., Vila, J., Piero, F. D., Paulsen, D. B., & Francis, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111976 · Cited by 66
“We also examined the gene expression of TGF-b, which is an important profibrotic marker [45].”
BackgroundEffects of Transforming Growth Factor-β1 on Human Vocal Fold Fibroblasts
Branski, R. C., Barbieri, S. S., Weksler, B. B., Saltman, B. E., Krishna, P. D., Kraus, D. H., Broadbelt, N. V., Chen, J., Poppas, D. P., & Felsen, D. (2009) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348940911800310 · Cited by 65
Lakshmi, S. P., Reddy, A. T., & Reddy, R. C. (2017) · Biochemical Journal · doi:10.1042/bcj20160943 · Cited by 69
Yasuoka, H., Jukic, D. M., Zhou, Z., Choi, A. M. K., & Feghali‐Bostwick, C. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22084 · Cited by 65
Papaioannou, I., Xu, S., Denton, C. P., Abraham, D. J., & Ponticos, M. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-06-0342 · Cited by 64
“Transforming growth factor β (TGFβ) is the master regulator of wound healing and the gene expression program drives myofibroblast differentiation and function (e.g., CTGF, COL1, α-SMA, EDA-fibronectin; Leask and Abraham, 2004).”
BackgroundInfluentialSelf-citationTissue engineered buccal mucosa for urethroplasty: Progress and future directions
Osman, N. I., Hillary, C. J., Bullock, A. J., MacNeil, S., & Chapple, C. R. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.006 · Cited by 66
MMP2 Activity is Critical for TGFβ2-Induced Matrix Contraction—Implications for Fibrosis
Eldred, J. A., Hodgkinson, L. M., Dawes, L. J., Reddan, J. R., Edwards, D. R., & Wormstone, I. M. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9457 · Cited by 70
Smad3 mediates TGF-β1-induced collagen gel contraction by human lung fibroblasts
Kobayashi, T., Liu, X., Wen, F., Kohyama, T., Shen, L., Wang, X., Hashimoto, M., Mao, L., Togo, S., Kawasaki, S., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.209 · Cited by 64
Xin, C., Ren, S., Eberhardt, W., Pfeilschifter, J. M., & Huwiler, A. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706452 · Cited by 64
“This obvious dual role of FTY720, that is, anti-inflammatory and profibrotic, is very reminiscent of the spectrum of actions of TGF-b, which has been extensively studied (Kitamura & Suto, 1997; Chen et al., 2003; Schnaper et al., 2003; Leask & Abraham, 2004; Xin et al., 2004a; Agrotis et al., 2005).”
BackgroundInfluentialAchillea asiatica extract and its active compounds induce cutaneous wound healing
Dorjsembe, B., Lee, H. J., Kim, M., Batsurén, D., Jigjid, T., & Nho, C. W. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.06.006 · Cited by 68
Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects
Tecilazich, F., Formenti, A. M., & Giustina, A. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09575-4 · Cited by 67
GLP-1 receptor agonist ameliorates experimental lung fibrosis
Fandiño, J., Toba, L., González-Matías, L. C., Diz-Chaves, Y., & Mallo, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-74912-1 · Cited by 59
Metadata
- Authors
- Leask, A., & Abraham, D. J.
- Affiliations
- The Royal Free Hospital (GB)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-05
- Volume
- 18
- Issue
- 7
- Pages
- 816-827
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2122808924
- Cited by
- 2,319
- References
- 153
- Citations by year
- 2026: 53 · 2025: 53 · 2024: 63 · 2023: 79 · 2022: 75 · 2021: 103 · 2020: 99 · 2019: 113 · 2018: 145 · 2017: 174 · 2016: 163 · 2015: 179 · 2014: 141 · 2013: 134 · 2012: 115
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Scleroderma Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- TGF-beta signaling, fibrosis, fibrogenesis, extracellular matrix deposition, connective tissue growth factor, ED-A fibronectin, TNF-α, interferon-gamma
- MeSH terms
- Animals, DNA-Binding Proteins, Fibronectins, Fibrosis, Gene Expression Regulation, Humans, Interferon-gamma, Tumor Necrosis Factor-alpha, Wound Healing, Signal Transduction, Trans-Activators, Transforming Growth Factor beta, Extracellular Matrix Proteins, Immediate-Early Proteins, Receptors, Transforming Growth Factor beta, MAP Kinase Signaling System, Intercellular Signaling Peptides and Proteins, Smad3 Protein, Smad4 Protein, Connective Tissue Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.